SLC6A10P: A Protein Interaction and Cancer, Neurodegenerative Diseases and Cardiovascular Disease Target

Target Name: SLC6A10P

NCBI ID: G386757

SLC6A10P

SLC6A10P: A Protein Interaction and Cancer, Neurodegenerative Diseases and Cardiovascular Disease Target

SLC6A10P is a protein that is expressed in various tissues throughout the body, including the brain, pancreas, and heart. It is a member of the SLC6A family, which is known for its role in transporting various molecules across cell membranes. One of the unique aspects of SLC6A10P is its ability to interact with the protein known as N-cadherin, which is a transmembrane protein that is involved in cell-cell adhesion.

SLC6A10P has been shown to play a role in the development and progression of various diseases, including cancer, neurodegenerative diseases, and cardiovascular disease. Its interaction with N-cadherin has also been linked to the regulation of cell growth and the development of cancer.

One of the most promising aspects of SLC6A10P is its potential as a drug target. Its interaction with N-cadherin makes it a promising target for small molecules that can modulate the activity of this protein. This has led to a great deal of interest in the development of compounds that can inhibit the activity of SLC6A10P and prevent its regulation of N-cadherin.

SLC6A10P has also been shown to play a role in the regulation of various cellular processes, including cell adhesion, migration, and the establishment of tissues. Its activity in these processes has been linked to the development of various diseases, including cancer and neurodegenerative diseases.

In addition to its potential as a drug target, SLC6A10P is also a potential biomarker. Its interaction with N-cadherin has been shown to be altered in various diseases, including cancer, neurodegenerative diseases, and cardiovascular disease. This suggests that SLC6A10P may be a useful biomarker for the diagnosis and treatment of these diseases.

Overall, SLC6A10P is a protein that has significant implications for our understanding of the development and progression of various diseases. Its interaction with N-cadherin and its ability to regulate cell processes make it a promising target for small molecules. As a drug target and biomarker, SLC6A10P has the potential to revolutionize our treatment of these diseases.

Protein Name: Solute Carrier Family 6 Member 10, Pseudogene

The "SLC6A10P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SLC6A10P comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets